|
at 16:10 |
|
|
Prothena Corporation plc , a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the first quarter of 2024 and provided...
|
|
at 16:10 |
|
|
Myomo, Inc. ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended...
|
|
at 16:10 |
|
|
QuidelOrtho Corporation (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, today announced financial results for the first...
|
|
at 16:10 |
|
|
Acadia Pharmaceuticals Inc. today announced its financial results for the first quarter ended March 31, 2024.
"In the first quarter of 2024, Acadia delivered net product sales of $205.8 million, representing 74% revenue growth year over year,...
|
|
at 16:10 |
|
|
Zai Lab Limited today announced financial results for the first quarter of 2024, along with recent product highlights and corporate updates.
"Our first quarter results demonstrate strong commercial execution and pipeline progress across our...
|
|
at 16:10 |
|
|
ChromaDex Corp. today announced financial results for the first quarter of 2024.
First Quarter 2024 Financial and Recent Operational Highlights
Total net sales were $22.2 million, with $17.4 million from Tru Niagen®.
Solid gross margin of...
|
|
|
